“Application of Excess Zero Methodology to Oral Health-Related Quality of Life: PEARL Network Findings”, in Society for Clinical Trials 32nd Annual Meeting, Vancouver, BC, Canada, 2011.
, “An Approach to Development and Dissemination of Patient Recruitment Materials for a Large Multi-Center Clinical Trial”, in 28th Annual Meeting of the Society for Clinical Trials, Montreal, Canada, 2007.
, “Assessing the Impact of a Genomic Classifier on Post-Operative Physician Decision-Making for Prostate Cancer Patients in Contemporary Clinical Management”, in 14th Annual Meeting of the Society of Urologic Oncology (SUO), Bethesda, MD, 2013.
, “Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
, “Association Between Center Point Thickness and Visual Acuity in SCORE Study Patients With Macular Edema Due to Retinal Vein Occlusion”, in American Academy of Ophthalmology Annual Meeting, Atlanta, GA, 2008.
, “Association for Research in Vision and Ophthalmology”, presented at the 2009, Ft. Lauderdale FL, 2009.
, “Association for Research in Vision and Ophthalmology (ARVO)”, presented at the 2009, Ft. Lauderdale FL, 2009.
, “Association of Cognitive Function and Depression with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2)”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
, “ASVA Home-Based Video Capture to Assess Function in People Living with Angelman Syndrome”, in FAST Summit - Foundation for Angelman Syndrome Therapeutics, Miami, FL, 2023.
, “Autologous vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Follicular Non-Hodgkins Lymphoma (FL) Beyond First Complete Response or First Partial Response”, in American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2008.
, “Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response.”, in ID Week 2014, Philadelphia, PA, 2014.
, “Baseline Nutritional Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Cohort”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
, “Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss”, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
, “The best single time point measurement correlations with AUC for cyclosporine and tacrolimus in HIV-1 infected liver and kidney transplant recipients (poster session)”, in World Congress of Nephrology, Vancouver, Canada, 2011.
, “BK and JC Polyomavirus (PyV) in HIV-1 Infected Kidney Transplant Recipients (KTR)”, in Interscience Conference on Antimicrobial Agents and Chemotherapy - ICAAC 2013, Denver, CO, 2013.
, “BK virus is not a significant cause of graft loss in HIV+ kidney recipients (oral presentation)”, presented at the 2011, Philadelphia, PA, 2011.
, “Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN)”, in College on Problems of Drug Dependence Meeting, San Diego, CA, 2013.
, “BOLD-100-001 (TRIO039): A phase Ib Dose-escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Gastrointestinal Solid Tumors”, in ASCO Annual Meeting, 2021.
, “Brightness, Contrast, and Color Balance of Digital vs. Film Retinal Images in the Age-Related Eye Disease Study 2”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
, “Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “Challenges and Best Practices for Recruitment and Retention During the COVID Pandemic.”, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
, “Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya”, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
, “Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
, “Change in Area of Intraretinal Macular Hemorrhages in Aflibercept- and Bevacizumab-treated Central Retinal and Hemiretinal Vein Occlusions: A SCORE2 Subanalysis”, in 43rd Annual Macula Society, San Diego, CA, 2020.
, “Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract).”, in 16th Annual ISCT (International Society for Cellular Therapy) Meeting, Philadelphia, 2010.
,